BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 28498393)

  • 1. Upregulation of circadian gene 'hClock' contribution to metastasis of colorectal cancer.
    Wang Y; Sun N; Lu C; Bei Y; Qian R; Hua L
    Int J Oncol; 2017 Jun; 50(6):2191-2199. PubMed ID: 28498393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. hClock gene expression in human colorectal carcinoma.
    Wang L; Chen B; Wang Y; Sun N; Lu C; Qian R; Hua L
    Mol Med Rep; 2013 Oct; 8(4):1017-22. PubMed ID: 23970287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian gene hClock enhances proliferation and inhibits apoptosis of human colorectal carcinoma cells in vitro and in vivo.
    Wang Y; Qian R; Sun N; Lu C; Chen Z; Hua L
    Mol Med Rep; 2015 Jun; 11(6):4204-10. PubMed ID: 25625359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels.
    Ding C; Luo J; Fan X; Li L; Li S; Wen K; Feng J; Wu G
    J Exp Clin Cancer Res; 2017 Apr; 36(1):56. PubMed ID: 28420432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitor of growth 4 suppresses colorectal cancer growth and invasion by inducing G1 arrest, inhibiting tumor angiogenesis and reversing epithelial-mesenchymal transition.
    Qu H; Yin H; Yan S; Tao M; Xie Y; Chen W
    Oncol Rep; 2016 May; 35(5):2927-35. PubMed ID: 26936485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NUBPL, a novel metastasis-related gene, promotes colorectal carcinoma cell motility by inducing epithelial-mesenchymal transition.
    Wang Y; Wu N; Sun D; Sun H; Tong D; Liu D; Pang B; Li S; Wei J; Dai J; Liu Y; Bai J; Geng J; Fu S; Jin Y
    Cancer Sci; 2017 Jun; 108(6):1169-1176. PubMed ID: 28346728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA CPS1-IT1 suppresses EMT and metastasis of colorectal cancer by inhibiting hypoxia-induced autophagy through inactivation of HIF-1α.
    Zhang W; Yuan W; Song J; Wang S; Gu X
    Biochimie; 2018 Jan; 144():21-27. PubMed ID: 29017924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancer.
    Ding C; Luo J; Li L; Li S; Yang L; Pan H; Liu Q; Qin H; Chen C; Feng J
    J Exp Clin Cancer Res; 2016 Jan; 35():5. PubMed ID: 26754532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GDF-15 Level Correlates with CMKLR1 and VEGF-A in Tumor-free Margin in Colorectal Cancer.
    Mielcarska S; Stopińska K; Dawidowicz M; Kula A; Kiczmer P; Seńkowska AP; Zajdel EN; Walkiewicz K; Waniczek D; Świętochowska E
    Curr Med Sci; 2021 Jun; 41(3):522-528. PubMed ID: 34169422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
    Yang Z; Wu D; Chen Y; Min Z; Quan Y
    Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LRG1 modulates epithelial-mesenchymal transition and angiogenesis in colorectal cancer via HIF-1α activation.
    Zhang J; Zhu L; Fang J; Ge Z; Li X
    J Exp Clin Cancer Res; 2016 Feb; 35():29. PubMed ID: 26856989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogene FOXK1 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition.
    Wu Y; Peng Y; Wu M; Zhang W; Zhang M; Xie R; Zhang P; Bai Y; Zhao J; Li A; Nan Q; Chen Y; Ren Y; Liu S; Wang J
    Oncotarget; 2016 Aug; 7(32):51150-51162. PubMed ID: 27223064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cadherin-12 enhances proliferation in colorectal cancer cells and increases progression by promoting EMT.
    Ma J; Zhao J; Lu J; Wang P; Feng H; Zong Y; Ou B; Zheng M; Lu A
    Tumour Biol; 2016 Jul; 37(7):9077-88. PubMed ID: 26762412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MLLT10 promotes tumor migration, invasion, and metastasis in human colorectal cancer.
    Jing X; Wu H; Cheng X; Chen X; Zhang Y; Shi M; Zhang T; Wang X; Zhao R
    Scand J Gastroenterol; 2018 Aug; 53(8):964-971. PubMed ID: 30102091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non‑coding RNA 00152 functions as a competing endogenous RNA to regulate NRP1 expression by sponging with miRNA‑206 in colorectal cancer.
    Chen ZP; Wei JC; Wang Q; Yang P; Li WL; He F; Chen HC; Hu H; Zhong JB; Cao J
    Int J Oncol; 2018 Sep; 53(3):1227-1236. PubMed ID: 29956750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NT5DC2 knockdown inhibits colorectal carcinoma progression by repressing metastasis, angiogenesis and tumor-associated macrophage recruitment: A mechanism involving VEGF signaling.
    Zhu Z; Hou Q; Guo H
    Exp Cell Res; 2020 Dec; 397(1):112311. PubMed ID: 32991874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIF-1α Promotes Epithelial-Mesenchymal Transition and Metastasis through Direct Regulation of ZEB1 in Colorectal Cancer.
    Zhang W; Shi X; Peng Y; Wu M; Zhang P; Xie R; Wu Y; Yan Q; Liu S; Wang J
    PLoS One; 2015; 10(6):e0129603. PubMed ID: 26057751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTBP3 contributes to colorectal cancer growth and metastasis via translational activation of HIF-1α.
    Hou P; Chen F; Yong H; Lin T; Li J; Pan Y; Jiang T; Li M; Chen Y; Song J; Zheng J; Bai J
    J Exp Clin Cancer Res; 2019 Jul; 38(1):301. PubMed ID: 31291975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short hairpin RNA- mediated gene knockdown of FOXM1 inhibits the proliferation and metastasis of human colon cancer cells through reversal of epithelial-to-mesenchymal transformation.
    Yang K; Jiang L; Hu Y; Yu J; Chen H; Yao Y; Zhu X
    J Exp Clin Cancer Res; 2015 May; 34(1):40. PubMed ID: 25935853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.